Abstract  

Diets for Non-Alcoholic Fatty Liver Disease

References

  1. Dowman JK, et al. QJM. 2010;103:71–83.
  2. Lau JK, et al. J Pathol. 2017;241:36–44.
  3. Haczeyni F, et al. J Gastroenterol Hepatol. 2018;33:1312–20.
  4. Van Herck MA, et al. Nutrients. 2017;9.
  5. Sahai A, et al. Am J Physiol Gastrointest Liver Physiol. 2004;287:G264–73.
  6. Weltman MD, et al. Gastroenterology. 1996;111:1645–53.
  7. Pickens MK, et al. Liver Int. 2010;30:1229–39.
  8. Pickens MK, et al. J Lipid Res. 2009;50:2072–82.
  9. Lee GS, et al. J Lipid Res. 2007;48:1885–96.
  10. Hussein O, et al. World J Gastroenterol. 2007;13:361–8.
  11. Bates JG, et al. US20180280394A1. USA; 2018.
  12. Tomita K, et al. Hepatology. 2014;59:154–69.
  13. Kirsch R, et al. J Gastroenterol Hepatol. 2003;18:1272–82.
  14. Liu X, et al. PLoS One. 2015;10:e0127352.
  15. Rinella ME, et al. J Hepatol. 2004;40:47–51.
  16. Matsumoto M, et al. Int J Exp Pathol. 2013;94:93–103.
  17. Chiba T, et al. PLoS One. 2016;11:e0164191.
  18. Tashiro K, et al. Hepatol Res. 2010;40:514–23.
  19. Fujita K, et al. Alcohol Clin Exp Res. 2010;34 Suppl 1:S18–24.
  20. Raubenheimer PJ, et al. Diabetes. 2006;55:2015–20.
  21. Wolf MJ, et al. Cancer Cell. 2014;26:549–64.
  22. Takeuchi-Yorimoto A, et al. Toxicol Appl Pharmacol. 2013;268:264–77.
  23. Allen PS, et al. Nutr Diet Suppl. 2015;7:77–85.
  24. Kulinski A, et al. J Biol Chem. 2004;279:23916–24.
  25. Caballero F, et al. J Biol Chem. 2010;285:18528–36.
  26. Vetelainen R, et al. J Gastroenterol Hepatol. 2007;22:1526–33.
  27. Kirpich IA, et al. J Nutr Biochem. 2011;22:38–45.
  28. Poulsen MM, et al. Nutr Res. 2012;32:701–8.
  29. Flores-Costa R, et al. Br J Pharmacol. 2018;175:953–67.
  30. Jensen VS, et al. Diabetol Metab Syndr. 2018;10:4.
  31. Ito M, et al. Hepatol Res. 2007;37:50–7.
  32. van der Heijden RA, et al. Aging (Albany NY). 2015;7:256–68.
  33. Ishimoto T, et al. Hepatology. 2013;58:1632–43.
  34. de Wit N, et al. Am J Physiol Gastrointest Liver Physiol. 2012;303:G589–99.
  35. Tzeng TF, et al. Phytomedicine. 2015;22:452–61.
  36. Romestaing C, et al. Nutr Metab (Lond). 2007;4:4.
  37. Anstee QM, et al. J Hepatol. 2010;53:542–50.
  38. Kohli R, et al. Hepatology. 2010;52:934–44.
  39. Kawasaki T, et al. J Nutr. 2009;139:2067–71.
  40. Svendsen P, et al. Mol Ther Methods Clin Dev. 2017;4:50–61.
  41. Savard C, et al. Hepatology. 2013;57:81–92.
  42. Basciano H, et al. Am J Physiol Endocrinol Metab. 2009;297:E462–73.
  43. Clapper JR, et al. Am J Physiol Gastrointest Liver Physiol. 2013;305:G483–95.
  44. Trevaskis JL, et al. Am J Physiol Gastrointest Liver Physiol. 2012;302:G762–72.
  45. Hinojosa G, et al. FASEB J. 2017;31:887.17.
  46. Boland M, et al. World J Gastroenterol. 2019;25:4904–20.
  47. Drescher HK, et al. Front Physiol. 2019;10.
  48. Han J, et al. Obesity (Silver Spring). 2017;25:1069–76.
  49. Machado MV, et al. PLoS One. 2015;10:e0127991.
  50. Ikawa-Yoshida A, et al. Int J Exp Pathol. 2017;98:221–33.
  51. Chong LW, et al. BMC Gastroenterol. 2015;15:22.
  52. Nakae D, et al. Cancer Res. 1992;52:5042–5.
  53. De Minicis S, et al. PLoS One. 2014;9:e97136.
  54. Svegliati-Baroni G, et al. Am J Pathol. 2006;169:846–60.
  55. Hill-Baskin AE, et al. Hum Mol Genet. 2009;18:2975–88.
  56. Kawashita E, et al. Sci Rep. 2019;9:204.